1 ely 5-fold on average compared with training
on PAGE.
2 On page 1, in the affiliations footnote, "Klinik fur Her
3 On page 1, the institutional affiliation for Elvira Donn
4 See an invited perspective on this article
on page 1043.This multicenter phase II study investigate
5 A new study (see related article beginning
on page 1049) reveals a previously unrecognized associat
6 blood flow (see the related study beginning
on page 106).
7 ard K. Vogel, and Edward Awh, which appeared
on pages 1128-1138 of the January 19, 2011 issue.
8 new study (see the related article beginning
on page 1142) reveals that it is not just the presence o
9 mphocytes (see the related article beginning
on page 1167).
10 On page 1203, in the first column, last paragraph, the s
11 On page 1204, in the second column, third complete parag
12 iferation (see the related article beginning
on page 1216).
13 e in mice (see the related article beginning
on page 1230).
14 new study (see the related article beginning
on page 1234) reports how TLR2 expression by endothelia
15 new study (see the related article beginning
on page 124) demonstrates that, after KSHV infection or
16 lood pressure (see related article beginning
on page 1244).
17 rculation (see the related article beginning
on page 1249).
18 settings (see the related articles beginning
on pages 1260 and 1270).
19 lated ECs (see the related article beginning
on page 1284).
20 sis of GN (see the related article beginning
on page 1286).
21 GGTase-I (see the related article beginning
on page 1294).
22 ibit HGP (see the related articles beginning
on pages 1306 and 1314).
23 se adults (see the related article beginning
on page 1322).
24 e aspects (see the related article beginning
on page 1354).
25 ne manner (see the related article beginning
on page 1360).
26 bilirubin (see the related article beginning
on page 137).
27 agonists (see the related article beginning
on page 1400).
28 mph nodes (see the related article beginning
on page 1405).
29 metformin (see the related article beginning
on page 1422).
30 ctivation (see the related article beginning
on page 1425).
31 acceptors (see the related article beginning
on page 1435).
32 l vectors (see the related article beginning
on page 1502).
33 receptors (see the related article beginning
on page 1514).
34 e animals (see the related article beginning
on page 1515).
35 ur et al. (see the related article beginning
on page 153) demonstrated that HSPGs under normal physio
36 stimulus (see the related article beginning
on page 1547).
37 mal HSCs (see the related articles beginning
on pages 1561 and 1581).
38 phenotype (see the related article beginning
on page 157).
39 lioration (see the related article beginning
on page 1595).
40 reuptake (see the related article beginning
on page 1595).
41 t in mice (see the related article beginning
on page 1616).
42 buminuria (see the related article beginning
on page 1645).
43 his issue (see the related article beginning
on page 165).
44 eutral pH (see the related article beginning
on page 1651).
45 infection (see the related article beginning
on page 1660).
46 phropathy (see the related article beginning
on page 1668).
47 n sensitivity (see related article beginning
on page 1686).
48 sor cells (see the related article beginning
on page 169).
49 uses FNDI (see the related article beginning
on page 1697).
50 entiation (see the related article beginning
on page 1707).
51 of Tregs (see the related article beginning
on page 1713).
52 a in rats (see the related article beginning
on page 1723).
53 nt, Stat1 (see the related article beginning
on page 1727).
54 halopathy (see the related article beginning
on page 173).
55 disease (see the related articles beginning
on pages 175, 185, and 195).
56 ial cells (see the related article beginning
on page 1756).
57 an others (see the related article beginning
on page 1762).
58 the JCI (see the related articles beginning
on pages 1796 and 1821) now report that obese adipose ti
59 ient mice (see the related article beginning
on page 1805).
60 opulation (see the related article beginning
on page 1806).
61 rrhythmia (see the related article beginning
on page 1814).
62 ease (PD) (see the related article beginning
on page 182).
63 rder zone (see the related article beginning
on page 1865).
64 s et al. (see the related articles beginning
on pages 1884 and 1893, respectively).
65 e the Editorial Commentary by Jehan and Qazi
on pages 190-1) BACKGROUND: Integrated Management of Chi
66 e the Editorial Commentary by Jehan and Qazi
on pages 190-1) Integrated Management of Childhood Illne
67 oimmunity (see the related article beginning
on page 2052).
68 estrained (see the related article beginning
on page 2062).
69 he heart (see the related articles beginning
on pages 2108, 2119, and 2128).
70 on cancer (see the related article beginning
on page 2111).
71 pregnancy (see the related article beginning
on page 2122).
72 fibrosis (see the related article beginning
on page 213).
73 throcytes (see the related article beginning
on page 2133).
74 diabetes (see the related article beginning
on page 2155).
75 + T cells (see the related article beginning
on page 2161).
76 nogenesis (see the related article beginning
on page 2171).
77 ein (APP) (see the related article beginning
on page 2190).
78 disorders (see the related article beginning
on page 2200).
79 therapy (see the related articles beginning
on pages 2225, 2233, and 2241).
80 aphylaxis (see the related article beginning
on page 2244).
81 variation (see the related article beginning
on page 225).
82 NOD mouse (see the related article beginning
on page 2252).
83 c hormone (see the related article beginning
on page 2260).
84 lammation (see the related article beginning
on page 2262).
85 r free Hb (see the related article beginning
on page 2271).
86 f the GBM (see the related article beginning
on page 2272).
87 ) T cells (see the related article beginning
on page 2279).
88 ent of HF (see the related article beginning
on page 229).
89 g obesity (see the related article beginning
on page 2291).
90 c neurons (see the related article beginning
on page 2325).
91 secretion (see the related article beginning
on page 2347).
92 ormations (see the related article beginning
on page 2356).
93 phenotype (see the related article beginning
on page 2366).
94 protein (see the related articles beginning
on pages 2385 and 2393).
95 imulation (see the related article beginning
on page 2456).
96 ble HDACs (see the related article beginning
on page 2459).
97 f the JCI (see the related article beginning
on page 246).
98 elucidated (see the related study beginning
on page 2468).
99 reported (see the related article beginning
on page 2500).
100 munocytes (see the related article beginning
on page 2517).
101 n in mice (see the related article beginning
on page 2526).
102 lase (sGC; see the related article beginning
on page 2552).
103 c setting (see the related article beginning
on page 2553).
104 f the JCI (see the related article beginning
on page 2574), have identified irritants that activate t
105 regulated (see the related article beginning
on page 258).
106 al weight (see the related article beginning
on page 2583).
107 gefitinib (see the related article beginning
on page 2609).
108 c therapy (see the related article beginning
on page 2610).
109 intestine (see the related article beginning
on page 2613).
110 ine VSMCs (see the related article beginning
on page 2634).
111 for eIF4E (see the related article beginning
on page 2638).
112 junctions (see the related article beginning
on page 266).
113 on (EMT) (see the related articles beginning
on pages 2663 and 2678, respectively).
114 e latter) (see the related article beginning
on page 2682).
115 nd memory (see the related article beginning
on page 272).
116 lization (see the related articles beginning
on pages 2745 and 2737, respectively).
117 emphysema in mice (see the related beginning
on page 2771).
118 n of MSCs (see the related article beginning
on page 2777).
119 ocarditis (see the related article beginning
on page 2799).
120 ter birth (see the related article beginning
on page 2808).
121 adipocyte (see the related article beginning
on page 2808).
122 ctivation (see the related article beginning
on page 2817).
123 ecipients (see the related article beginning
on page 2845).
124 ith MPS I (see the related article beginning
on page 2868).
125 n program (see the related article beginning
on page 2898).
126 In the companion article
on pages 3010-3021, we analyze how the measured kinetics
127 outcomes (see the related article beginning
on page 3026).
128 an AD-HSP (see the related article beginning
on page 3026).
129 in VSMCs (see the related article beginning
on page 303).
130 or (AT1R) (see the related article beginning
on page 3045).
131 use liver (see the related article beginning
on page 305).
132 systems (see the related articles beginning
on pages 3051 and 3065, respectively).
133 del of AD (see the related article beginning
on page 3060).
134 ne system (see the related article beginning
on page 3070).
135 er injury (see the related article beginning
on page 3072).
136 s reduced (see the related article beginning
on page 3102).
137 This "smart cell patch", described
on page 3115, effectively regulates the blood glucose le
138 c hypoxia (see the related article beginning
on page 3128).
139 d embryos (see the related article beginning
on page 3160).
140 e for fat (see the related article beginning
on page 3177).
141 mechanism (see the related article beginning
on page 3188).
142 h factors (see the related article beginning
on page 3198).
143 On page 320, R. R. Lunt and co-workers demonstrate elect
144 use model (see the related article beginning
on page 3204).
145 agulation (see the related article beginning
on page 3208).
146 a facile roll-to-plate process, as described
on page 3209.
147 te number (see the related article beginning
on page 3220).
148 d healing (see the related article beginning
on page 3277).
149 syndrome (see the related article beginning
on page 3291).
150 scribed by Q.-D. Shen, Z. Gu, and co-workers
on page 3313.
151 response (see the related article beginning
on page 3330).
152 ngiocytes (see the related article beginning
on page 3331).
153 nfections (see the related article beginning
on page 3339).
154 r disease (see the related article beginning
on page 3384).
155 nt of T1D (see the related article beginning
on page 3390).
156 human MS (see the related article beginning
on page 3403).
157 to HNSCC (see the related article beginning
on page 3408).
158 nal cells (see the related article beginning
on page 3437).
159 ptor PAR2 (see the related article beginning
on page 3453).
160 egulation (see the related article beginning
on page 3462).
161 structure (see the related article beginning
on page 353).
162 inal cord (see the related article beginning
on page 3530).
163 On page 3549, V. V. Tsukruk and co-workers develop self-
164 epitopes (see the related article beginning
on page 3563).
165 As described
on page 3564, the sequential patterning approach enables
166 studies (see the related articles beginning
on pages 357 and 370) use lamin A/C-deficient mice, whic
167 response (see the related article beginning
on page 3576).
168 in humans (see the related article beginning
on page 3583).
169 is added (see the related article beginning
on page 3651).
170 (See the Editorial Commentary by Martin
on pages 368-9.)Using population-based surveillance data
171 n in vivo (see the related article beginning
on page 3684).
172 potential (see the related article beginning
on page 369).
173 A (miRNA) (see the related article beginning
on page 3714).
174 rix is presented by C. Majidi and co-workers
on page 3726.
175 ents them (see the related article beginning
on page 3753).
176 llografts (see the related article beginning
on page 3774).
177 arcinomas (see the related article beginning
on page 3846).
178 n B cells (see the related article beginning
on page 3857).
179 in (TSLP) (see the related article beginning
on page 3868).
180 pogenesis (see the related article beginning
on page 387).
181 in vitro (see the related article beginning
on page 3917).
182 orylation (see the related article beginning
on page 3930).
183 esorption (see the related article beginning
on page 3954).
184 t in part (see the related article beginning
on page 3966).
185 tem cells (see the related article beginning
on page 3988).
186 nd death (see the related articles beginning
on pages 40 and 29, respectively).
187 duration (see the related article beginning
on page 4022).
188 r balance (see the related article beginning
on page 4025).
189 X. Zhao and co-workers develop
on page 4035 a new biocompatible hydrogel system that is
190 structure (see the related article beginning
on page 4044).
191 reports (see the related articles beginning
on pages 415 and 440) reveals that intrinsic T cell reac
192 tagenesis (see the related article beginning
on page 434) defined a new disorder of branched-chain am
193 sing, devices, and applications is discussed
on page 4397 by A. Javey and co-workers.
194 nted by H.-K. Baik, U. Jeong, and co-workers
on page 4455.
195 m is reported by J. A. Rogers and co-workers
on page 4462.
196 e pathway (see the related article beginning
on page 448).
197 IFN-gamma (see the related article beginning
on page 451).
198 On page 4684, C. Dames, L. Hu and co-workers report high
199 infection (see the related article beginning
on page 473).
200 MT events (see the related article beginning
on page 482).
201 As described
on page 4871, in each bundle, small gaps are formed betw
202 formation (see the related article beginning
on page 491).
203 direction (see the related article beginning
on page 492).
204 On page 4998, S. Yin, R. H. Baughman, and co-workers dem
205 As described
on page 5088, this reversible adhesive allows miniature
206 use model (see the related article beginning
on page 526).
207 s setting (see the related article beginning
on page 560).
208 Fornasiero and co-workers, as described
on page 5871, for application as a key component of prot
209 On page 5939, J. V. Badding and co-workers describe the
210 On page 6207, Y. Zhang, Z. Liu and co-workers describe m
211 cussed by X. Li, L. Colombo, and R. S. Ruoff
on page 6247.
212 of p-tau (see the related article beginning
on page 648).
213 ls to OME (see the related article beginning
on page 651).
214 aging ROS (see the related article beginning
on page 659).
215 ogenitors (see the related article beginning
on page 663).
216 On Page 6705, C. George, M. De Volder, and co-workers de
217 myocytes (see the related article beginning
on page 675).
218 ic states (see the related article beginning
on page 683).
219 h another part of the Codex, a complex table
on pages 69--74, reveals a concern on the part of the an
220 new paper (see the related article beginning
on page 701) demonstrates that LCs utilize these markers
221 oantigens (see the related article beginning
on page 712), some of which are associated with autoimmu
222 ly normal (see the related article beginning
on page 743).
223 me of HDL (see the related article beginning
on page 746).
224 lammation (see the related article beginning
on page 757).
225 entations (see the related article beginning
on page 765).
226 l nephron (see the related article beginning
on page 773).
227 a in mice (see the related article beginning
on page 79).
228 n in mice (see the related article beginning
on page 837).
229 rtension (see the related articles beginning
on pages 868 and 879, respectively).
230 acquisita (see the related article beginning
on page 870).
231 nhibitors (see the related article beginning
on page 876).
232 diseases (see the related article beginning
on page 888).
233 perfusion (see the related article beginning
on page 910).
234 ignaling (see the related articles beginning
on pages 93 and 103, respectively).
235 in humans (see the related article beginning
on page 936).
236 mal cells (see the related article beginning
on page 940).
237 and G-CSF (see the related article beginning
on page 946).
238 erentiate (see the related article beginning
on page 953).
239 the liver (see the related article beginning
on page 956).
240 new study (see the related article beginning
on page 96) shows that blocking the effect of GH in the
241 arthritis (see the related article beginning
on page 961).
242 pulations (see the related article beginning
on page 974).
243 in sepsis (see the related article beginning
on page 984).
244 nsmission (see the related article beginning
on page 99).
245 tionally, a further error has been corrected
on page five in the sentence: Subsequent improvements to